Recruiting Now
24/7 Call/Text: (208) 502-3039
Infant Care ResearchCurrently Recruiting

Infant Pneumococcal Vaccine Study

💰 Up to$2,200
Financial Compensation Available

Help advance pediatric immunization science by participating in an FDA-regulated infant pneumococcal vaccine clinical research trial. Qualified infant participants receive all study-related medical care and vaccines at no cost.

Infant Pneumococcal Vaccine Study

Study Eligibility Criteria

Candidates must meet the following baseline requirements. Final qualification is determined during our free pre-screening visit.

  • Infants between 42 and 89 days of age at enrollment
  • In overall good health as determined by medical history and clinical exam
  • Parent or legal guardian available to attend scheduled clinic visits in Idaho Falls
  • Has not received prior pneumococcal conjugate vaccines

Participant Benefits & Support

Participating in this clinical research trial includes the following provided at no cost:

Financial compensation for parent/guardian time and travel expenses
No-cost study vaccines administered by specialized pediatric clinical staff
No-cost well-baby health monitoring and physical exams during study visits
Direct contribution to future infant health protection against pneumococcal disease

Childhood Immunization Schedule

A helpful reference timeline of routine childhood immunizations. Your study visits align with these standard well-baby milestones.

Birth (given at hospital)
  • Hepatitis B
2 Month (given at LCR office)
  • Vaxelis (Hep B, DTaP, IPV, Hib)
  • Pneumococcal
  • Rotateq
4 Month (given at LCR office)
  • Vaxelis (Hep B, DTaP, IPV, Hib)
  • Pneumococcal
  • Rotateq
6 Month (given at LCR office)
  • Vaxelis (Hep B, DTaP, IPV, Hib)
  • Pneumococcal
  • Rotateq
12 Month (given at LCR office)
  • MMR
  • Varicella
  • Pneumococcal
  • Havrix (Hep A)

Protocol FAQs

No. All study vaccines, clinical examinations, lab work, and visits are provided at zero cost to your family. You will also be financially compensated for your time and travel.

Protocol Snapshot

Estimated Duration
Approximately 6–12 months
Study Medication / Intervention
FDA-investigational pneumococcal conjugate vaccine
Study Location
Leavitt Clinical Research, 3339 Valencia Dr, Idaho Falls, ID 83404
📍 Facility Address: 3339 Valencia Dr, Idaho Falls, ID 83404. Free on-site participant parking available.